ChartRow logo
ChartRow
Investing Charts
Sign in
EW
Edwards Lifesciences CorporationStock · HealthcareS&P 500 0.1%
$82.64−$1.18 (-1.41%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

How Edwards Lifesciences uses its cash

Period

Where does Edwards Lifesciences's cash go? This Sankey traces cash from net income through operating cash flow into capex, free cash flow, dividends, buybacks, and debt paydown. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Edwards Lifesciences Corporation · FY2025 · year ended 2025-12-31
Operating cash flow$1.6BNet income$1.1B · 67%D&A$157M · 10%Stock comp$158M · 10%Working capital$207M · 13%Free cash flow$1.3B · 84%Capex$260M · 16%Buybacks$893M · 56%Cash retained$442M · 28%

Each fiscal year from SEC filings. Percentages are share of operating cash flow. Sources (net income + non-cash add-backs) flow into operating cash flow, which splits into capex and free cash flow; free cash flow goes to dividends, buybacks, debt paydown, and what's retained. Annual only. For informational purposes only.